
Universal Health Services statistics
$194.07+0.12%Close 13 Nov 2026
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
| Enterprise value | $17.99B |
|---|
| EV / EBITDA | 6.78 |
|---|
| EV / sales | 0.98 |
|---|
Share price
| Latest close | $194.07 |
|---|
| Day's change | +0.1% |
|---|
| 52-week high | $246.33 |
|---|
| 52-week low | $140.08 |
|---|
| From 52-week high | −21.2% |
|---|
| Return · 1 month | +4.8% |
|---|
| Return · 3 months | +12.3% |
|---|
| Return · year to date | −11.0% |
|---|
| Return · 1 year | −15.0% |
|---|
| Beta · 1 year against the S&P 500 | 0.14 |
|---|
| 50-day average | $181.19 |
|---|
| 200-day average | $176.46 |
|---|
| RSI 14 | 58.9 |
|---|
| Average volume · 20 sessions | 764K |
|---|
Margins and returns
For fiscal 2025, as filed.
| Operating margin | 11.5% |
|---|
| Net margin | 8.6% |
|---|
| Free cash flow margin | 4.9% |
|---|
| Return on equity | 21.4% |
|---|
| Return on assets | 10.2% |
|---|
| Return on invested capital | 12.1% |
|---|
| Return on capital employed | 16.2% |
|---|
| Stock-based compensation / revenue | 0.6% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $137.8M |
|---|
| Total debt | $5.17B |
|---|
| Net debt | $5.03B |
|---|
| Current ratio | 1.05 |
|---|
| Debt / equity | 0.71 |
|---|
| Net debt / EBITDA | 1.92 |
|---|
| Interest coverage | 12.78 |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 64.5M |
|---|
| Net share repurchases | $951.2M |
|---|
| Dividends per share | $0.80 |
|---|
| Dividend payout | 3.4% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $461.0M |
|---|
| Effective tax rate | 23.4% |
|---|
UHS in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.